Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases

American Journal of Surgery

Volumn 177, Issue 1, 1999, Pages 2-6

  Bakalakos, Efthimios A ^a   Burak Jr , William E ^a   Young, Donn C ^b   Martin Jr , Edward W ^a  

^a Division of Surgical Oncology   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; COLON RESECTION; COLORECTAL CANCER; FOLLOW UP; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RECTUM RESECTION; TREATMENT OUTCOME;

CARCINOEMBRYONIC ANTIGEN; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033036765     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(98)00303-1     Document Type: Article

References (24)

1. Gold P., Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 121:1965;439-462.
2. Carcinoembryonic antigen: its role as a marker in the management of cancer. A National Institutes of Health Consensus Development Conference. Ann Intern Med. 94:1981;407-409.
3. Rice C.D., Nelson H. Tumor markers in colorectal cancer predictors of risk . Semin Colon Rectal Surg. 7:1996;16-30.
4. Martin E.W., Minton J.P., Carey L.C. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg. 202:1985;310-317.
5. Fortner J.G., Silva J.S., Golbey R.B., et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg. 199:1984;306-316.
6. Fong Y., Cohen A.M., Fortner J.G., et al. Liver resection for colorectal metastases. J Clin Oncol. 15:1997;938-946.
7. McCall J.L., Black R.B., Rich C.A., et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 37:1994;875-881.
8. Fletcher R.H. Carcinoembryonic antigen. Ann Intern Med. 104:1986;66-73.
9. Moertel C.G., Fleming T.R., Macdonald J.S., et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 270:1993;943-947.
10. Northover J. Carcinoembryonic antigen and recurrent colorectal cancer. Gut. 27:1986;117-122.
11. Wolf R.F., Cohen A.M. The miniscule benefit of serial carcinoembryonic antigen monitoring after curative treatment for primary colorectal cancer. J Am Coll Surg. 185:1997;60-64.
12. Bakalakos E.A., Kim J.A., Young D.C., Martin E.W. Determinants of survival following hepatic resection for metastatic colorectal cancer. World J Surg. 22:1998;399-405.
13. Steele G., Bleday R., Mayer R.J., et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver. Gastrointestinal tumor study group protocol 6584. J Clin Oncol. 9:1991;1105-1112.
14. Gwin J.L., Sigurdson E.R. Surgical considerations in nonhepatic intra-abdominal recurrence of carcinoma of the colon. Semin Oncol. 20:1993;520-527.
15. Rosen C.B., Nagorney D.M., Taswell H.F., et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg. 216:1992;493-505.
16. Martin E.W., James K.K., Hurtubise P.E., et al. The use of CEA as an early indicator for gastrointestinal tumor recurrence and second-look procedures. Cancer. 39:1977;440-446.
17. Sardi A. Multiple operations for recurrent colorectal cancer. Semin Surg Oncol. 7:1991;146.
18. Herrera M.A., Ming Chu T., Holyoke E.D., et al. CEA monitoring of palliative treatment for colorectal carcinoma. Ann Surg. 1977;23-30.
19. Hughes K.S., Simon R., Songhorabodi S., et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases. Surgery. 103:1988;278-288.
20. Adam R., Bismuth H., Castaing D., et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg. 225:1997;51-62.
21. Wang J.Y., Tang R., Chiang J.M. Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 37:1994;272-277.
22. Ohlsson B., Stenram U., Tranberg K.G. Resection of colorectal liver metastases 25-year experience . World J Surg. 22:1998;268-277.
23. Cady B., Jenkins R.L., Steele G.D., et al. Surgical margin in hepatic resection for colorectal metastasis. Ann Surg. 227:1998;566-571.
24. Thoeni R.F. Colorectal cancer. Radiologic staging. Radiol Clin North Am. 35:1997;457-485.